novartis ag-reg (NOVN:SIX Swiss Ex)
Enrico Vanni Ph.D.
Vice Chairman, Chairman of Compensation Committee, Member of Audit & Compliance Committee and Member of Research & Development Committee, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 36 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Enrico Vanni, Ph.D., serves as an Independent Consultant of Eclosion (private equity for biotechs), Denzler&Partners (management resources) and Mbcp (private banking). Dr. Vanni has more than 30 years of healthcare management experience. He served as head of the European pharmaceutical practice for McKinsey&Company. He started his career in 1977 with IBM in San Jose, California, and joined McKinsey & Company in Zurich, Switzerland. He managed the Geneva Office from ...
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*
Director, Member of Audit Committee and Member of Nominating/Corporate Governance Committee
Vice Chairman, Chairman of Compensation Committee, Member of Audit & Compliance Committee and Member of Research & Development Committee
Université de Lausanne
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|€700.0K||Compensation as of Fiscal Year 2013.|